5 Large Drug Stocks That Are Poised to Ride on Sector Recovery
The sky-high tariffs imposed by the United States and retaliatory tariffs by China and some other countries hurt global stock markets in April. With the massive tariffs imposed by the United States and China currently on a pause, the markets recovered slightly. However, this is only a temporary suspension. The uncertainty around tariffs and trade production measures remains, which has muted economic growth.However, amid the broader macro uncertainty, the drug and biotech sector seems to have recovered in th ...